Trade MESO stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
Mesoblast Limited American Depositary Shares (MESO) is trading at US$15.13, up 1.75% today as of Sep 18, 16:00 EDT. The company has a market capitalisation of US$2.2B. Over the past 52 weeks, MESO has traded between US$13.05 and US$21.50. On Syfe you can trade MESO with $0 commission and add it to your watchlist.
| Previous close | US$14.87 |
|---|---|
| Market cap | US$2.2B |
| 52-week range | US$13.05 – US$21.50 |
| Volume | 215.7K |
| Exchange | US |
Add to Watchlist
Set Price Alert
Mesoblast Limited American Depositary Shares
Mesoblast Ltd. is a biopharmaceutical company, which engages in the research, development, and market of mesenchymal lineage adult stem cell technology platform. Its medicines target cardiovascular diseases, spine orthopedic disorders, oncology and hematology, immune-mediated, and inflammatory diseases. The company was founded by Silviu Itescu on June 8, 2004 and is headquartered in Melbourne, Australia.
Year: 2009
Sector Update: Healthcare Stocks Mixed Monday Afternoon
Aug 17, 5:38 PM · MT Newswires
Sector Update: Healthcare Stocks Mixed Premarket Monday
Aug 17, 1:18 PM · MT Newswires
Mesoblast Completes Patient Treatment in Phase 3 Trial of Chronic Low Back Pain
Aug 17, 8:13 AM · MT Newswires
Mesoblast Completes Treatment Target in Phase 3 Back Pain Trial
Jul 14, 8:17 AM · MT Newswires
Stay on top of MESO
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
Popular Stocks in Singapore
